Gedea Biotech Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$2.65M
- Investors
-
16
Gedea Biotech General Information
Description
Developer of an antibiotic-free treatment intended to treat and prevent vaginal bacterial and fungal infections. The company's treatment offers natural substances that restore the vaginal pH level as well as provide physical barrier protection and inhibit biofilm formation, enabling women to have an antibiotic-free, safe and effective treatment.
Contact Information
Website
www.gedeabiotech.comCorporate Office
- Medicon Village
- Scheeletorget 1
- 223 81 Lund
- Sweden
Corporate Office
- Medicon Village
- Scheeletorget 1
- 223 81 Lund
- Sweden
Gedea Biotech Timeline
Gedea Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Grant | 08-Nov-2023 | $2.65M | Completed | Clinical Trials - Phase 2 | ||
| 11. Later Stage VC | 05-Jun-2023 | Completed | Clinical Trials - Phase 2 | |||
| 10. Grant | 04-Apr-2023 | Completed | Startup | |||
| 9. Later Stage VC | 31-Dec-2020 | Completed | Clinical Trials - Phase 2 | |||
| 8. Grant | 11-Dec-2019 | Completed | Startup | |||
| 7. Early Stage VC | 31-Dec-2018 | Completed | Startup | |||
| 6. Grant | 05-Dec-2018 | Completed | Startup | |||
| 5. Accelerator/Incubator | 01-Jan-2018 | Completed | Startup | |||
| 4. Early Stage VC | 22-Dec-2017 | $1.31M | $1.34M | Completed | Startup | |
| 3. Grant | 21-Nov-2017 | $107K | $32.5K | Completed | Pre-Clinical Trials |
Gedea Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preference | ||||||||
| Preference | ||||||||
| Preference | 27,500 | $47.83 | $47.83 | 1x | $47.83 | 24.1% |
Gedea Biotech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Gedea Biotech Patents
Gedea Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4324465-A1 | Compounds for use in the treatment of a microbial infection in the urogenital system | Pending | 15-Aug-2022 | ||
| US-20220193031-A1 | Vaginal tablet formulation | Pending | 05-Apr-2019 | ||
| AU-2020252268-A1 | Vaginal tablet formulation | Pending | 05-Apr-2019 | ||
| EP-3976000-A1 | Vaginal tablet formulation | Active | 05-Apr-2019 | ||
| CA-3134086-A1 | Vaginal tablet formulation | Pending | 05-Apr-2019 | A61K31/366 |
Gedea Biotech Executive Team (7)
| Name | Title | Board Seat |
|---|---|---|
| Annette Säfholm Ph.D | Chief Executive Officer | |
| Helena Strevens Ph.D | Co-Founder, Medical Officer & Board Member | |
| Ulf Ellervik | Co-Founder & Board Member | |
| Olov Sterner Ph.D | Co-Founder | |
| Sophie Manner Ph.D | Co-Founder |
Gedea Biotech Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| Antonius Berkien | Self | President & Chairman | |
| Helena Strevens Ph.D | Gedea Biotech | Co-Founder, Medical Officer & Board Member | |
| Mats Persson | Self | Board Member | |
| Per Antonsson Ph.D | Almi Invest | Board Member | |
| Peter Enberg | Self | Board Member |
Gedea Biotech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Gedea Biotech Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| European Innovation Council Fund | Venture Capital | Minority | ||
| Additio Capital | Venture Capital | Minority | ||
| Additio Investment Group | Venture Capital | Minority | ||
| Capitral | Venture Capital | Minority | ||
| Horizon 2020 SME Instrument | Government |
Gedea Biotech FAQs
-
When was Gedea Biotech founded?
Gedea Biotech was founded in 2015.
-
Who is the founder of Gedea Biotech?
Helena Strevens Ph.D, Ulf Ellervik, Olov Sterner Ph.D, and Sophie Manner Ph.D are the founders of Gedea Biotech.
-
Who is the CEO of Gedea Biotech?
Annette Säfholm Ph.D is the CEO of Gedea Biotech.
-
Where is Gedea Biotech headquartered?
Gedea Biotech is headquartered in Lund, Sweden.
-
What is the size of Gedea Biotech?
Gedea Biotech has 4 total employees.
-
What industry is Gedea Biotech in?
Gedea Biotech’s primary industry is Drug Discovery.
-
Is Gedea Biotech a private or public company?
Gedea Biotech is a Private company.
-
What is Gedea Biotech’s current revenue?
The current revenue for Gedea Biotech is .
-
How much funding has Gedea Biotech raised over time?
Gedea Biotech has raised $6.15M.
-
Who are Gedea Biotech’s investors?
European Innovation Council Fund, Additio Capital, Additio Investment Group, Capitral, and Horizon 2020 SME Instrument are 5 of 16 investors who have invested in Gedea Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
